首页 › 基金 › Affinity Asset Advisors, LLC › OVID
Affinity Asset Advisors, LLC 对 OVID 的持仓历史
OVID THERAPEUTICS INC · 医疗保健
Affinity Asset Advisors, LLC 在 Q3 2026 的 13F 申报中披露持有 OVID(OVID THERAPEUTICS INC)10,144,562 股,市值约 US$25.3M,约占其申报组合的 1.18%,在其申报持仓中市值排名第 23 位。 Affinity Asset Advisors, LLC 最近 7 个申报季度中有 7 个季度披露了 OVID 持仓,最早可追溯至 Q1 2025。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Affinity Asset Advisors, LLC 对 OVID 的持仓演变
Affinity Asset Advisors, LLC 于 Q1 2025 首次披露 OVID 持仓:667,516 股(约 US$208K)。 该持仓在 Q2 2026 达到峰值 10,144,562 股,市值约 US$27.3M。 在 7 次申报中,Affinity Asset Advisors, LLC 3 次增持、1 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 10,144,562 股、市值约 US$25.3M。 持仓曾出现大幅变动:Q3 2025 增持约 297% (随后一个季度股价上涨 25%)、Q4 2025 增持约 170% (随后一个季度股价上涨 36%)、Q1 2026 增持约 49% (随后一个季度股价上涨 21%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2025 | 667.52K | $208.20K | 新进 |
| Q2 2025 | 667.52K | $220.21K | 持有 |
| Q3 2025 | 2.65M | $3.44M | 增持 |
| Q4 2025 | 7.15M | $11.65M | 增持 |
| Q1 2026 | 10.64M | $23.61M | 增持 |
| Q2 2026 | 10.14M | $27.29M | 减持 |
| Q3 2026 | 10.14M | $25.26M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 OVID 与 13F 数据
OVID(OVID THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 53 只申报持有 OVID,申报仓位最大的包括:ADAR1 Capital Management, LLC (US$20.0M), SILVERARC CAPITAL MANAGEMENT, LLC (US$14.8M), STEMPOINT CAPITAL LP (US$6.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 OVID 的基金
- ADAR1 Capital Management, LLC 7.42M 股 · $19.95M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 5.95M 股 · $14.82M · Q3 2026
- STEMPOINT CAPITAL LP 2.42M 股 · $6.50M · Q2 2026
- Ikarian Capital, LLC 2.27M 股 · $6.11M · Q2 2026
- Rosalind Advisors, Inc. 1.11M 股 · $2.98M · Q2 2026
- Sio Capital Management, LLC 1.01M 股 · $2.70M · Q2 2026
- Propel Bio Management, LLC 1.02M 股 · $2.54M · Q3 2026
- Saturn V Capital Management LP 663.06K 股 · $1.78M · Q2 2026
- Ally Bridge Group (NY) LLC 624.56K 股 · $1.68M · Q2 2026
更多关于 Affinity Asset Advisors, LLC
常见问题
How long has Affinity Asset Advisors, LLC held OVID?
Affinity Asset Advisors, LLC has disclosed OVID holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Affinity Asset Advisors, LLC's current position in OVID?
As of Q3 2026, Affinity Asset Advisors, LLC holds 10.14M shares of OVID (OVID THERAPEUTICS INC), valued at $25.26M, representing 1.18% of its reported portfolio and ranking #23.
Has Affinity Asset Advisors, LLC been buying or selling OVID?
In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC held unchanged its position in OVID. The position peaked in Q2 2026 at 10.14M shares.
Which other funds hold OVID?
Other major institutional holders of OVID include ADAR1 Capital Management, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, STEMPOINT CAPITAL LP, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.